Ina Kötter
Ina Kötter is an expert in Rheumatology at University Medical Center Hamburg-Eppendorf (Germany). As of October 2026, ScienceLeadR ranks Ina Kötter in the top 1% of experts worldwide for Vasculitis, Arthritis and Skin Diseases, Vascular. Ina Kötter has authored 370 publications, the most recent in 2026, and is an investigator in 4 clinical trials, 2 of them ongoing. SLR score: 982 (community average: 125). How the SLR is computed.
LeadR Profile
Rheumatology
Subspecialties: Internal Medicine - Immunology - Dermatology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1990 - 2026
Number : 370
Citations
Main journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| [New developments in immunomodulation of idiopathic inflammatory myopathies]. PMID 42944784 — muscular diseases, cells, immunomodulation, plasma cells, arthritis, rheumatic diseases, myositis, therapeutics, t-lymphocytes, b-lymphocytes | Z Rheumatol | 2026 | 0 |
| [Revision of the model special training regulations 2026]. PMID 42789090 — rheumatology, internal medicine, arthritis, rheumatic diseases | Z Rheumatol | 2026 | 0 |
| Two cases of probable Neuro-Behçet syndrome treated with autologous HSCT. PMID 42516391 — microscopy, electron, scanning transmission, myelitis, behcet syndrome, immune system diseases, brain stem, therapeutics, wounds and injuries | Front Immunol | 2026 | 0 |
| A patient-derived benchmark for evaluating large language models in connective tissue diseases: blinded multi-stakeholder assessment and guideline comparison. PMID 42443611 — rheumatology, empathy, language, connective tissue, rheumatologists, multiple chronic conditions, connective tissue diseases, physicians, tissues | Rheumatol Int | 2026 | 1 |
| VEXAS syndrome in a female with constitutional monosomy X. PMID 42367666 — aged, monosomy | EULAR Rheumatol Open | 2025 | 0 |
Clinical Studies 4
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 7
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Phase 2 Placebo controlled Study to Assess the Safety Efficacy and PK of ESK 001 in SLE 2022-502105-15-00 — safety, lupus erythematosus, systemic, pharmacokinetics | Phase 2 | Active not recruiting | 2023 |
| A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis NCT06655155 — sclerosis, safety, syringes, scleroderma, systemic, pharmacokinetics | Phase 2 | Active not recruiting | 2024 |
LeadR Networks
Main global connection map